NCT03806595View on ClinicalTrials.gov

A Pilot Study of Intranasal Lidocaine in Acute Management of Pediatric Migraine

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 3, 2019

Primary Completion Date

December 3, 2020

Study Completion Date

December 3, 2020

Conditions
Migraine in ChildrenPosttraumatic Headache
Interventions
DRUG

Lidocaine 2% Injectable Solution

The Barre method of intranasal administration will be used to instil 1mL of lidocaine 2% in either the nostril ipsilateral to the headache or 1ml in each nostril in cases of bilateral headache.

DRUG

Normal Saline Flush, 0.9% Injectable Solution

The Barre method of intranasal administration will be used to instil 1mL of saline 0.9% in either the nostril ipsilateral to the headache or 1ml in each nostril in cases of bilateral headache.

Trial Locations (1)

V6H 3N1

BC Children's Hospital, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT03806595 - A Pilot Study of Intranasal Lidocaine in Acute Management of Pediatric Migraine | Biotech Hunter | Biotech Hunter